30 employees
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
2020
$50M
from 1 investors over 1 rounds
Cimeio Therapeutics raised $50M on April 13, 2022
Investors: Versant Ventures